Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(14%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
14%
Ph phase_1
3
43%
Ph phase_2
2
29%
Ph early_phase_1
1
14%

Phase Distribution

4

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
3(42.9%)
Phase 2Efficacy & side effects
2(28.6%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(1)
Other(5)

Detailed Status

unknown4
Completed1
Recruiting1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (14.3%)
Phase 13 (42.9%)
Phase 22 (28.6%)
N/A1 (14.3%)

Trials by Status

completed114%
unknown457%
recruiting114%
suspended114%

Recent Activity

1 active trials
Showing 5 of 7
suspendedphase_2

The Safety and Efficiency Study of Mesenchymal Stem Cell (19#iSCLife®-POI) in Premature Ovarian Insufficiency

NCT03816852
recruitingphase_1

HUC-MSC for Treatment of High-risk HPV Infection

NCT06610773
completedearly_phase_1

Clinical Study of hUC-MSCs Treating Decompensated Liver Cirrhosis With HBV

NCT05442437
unknownnot_applicable

Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease

NCT05531266
unknownphase_1

Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy

NCT05507697
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT03816852Phase 2

The Safety and Efficiency Study of Mesenchymal Stem Cell (19#iSCLife®-POI) in Premature Ovarian Insufficiency

Suspended
NCT06610773Phase 1

HUC-MSC for Treatment of High-risk HPV Infection

Recruiting
NCT05442437Early Phase 1

Clinical Study of hUC-MSCs Treating Decompensated Liver Cirrhosis With HBV

Completed
NCT05531266Not Applicable

Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease

Unknown
NCT05507697Phase 1

Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy

Unknown
NCT02745808Phase 1

Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With Diabetes

Unknown
NCT02223897Phase 2

Mesenchymal Stem Cells Transplantation for Ischemic-type Biliary Lesions

Unknown

All 7 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
7